Cytori Therepeutics Featured in Wired Magazine

Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.

Read more »

OneMedPlace Announces “OneMedForum 2011” Finance Conference for Emerging Healthcare and Life Science Companies

OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.

Read more »

Growing Regenerative Medicine Market Provides Opportunities for Cytori Therapeutics

For many breast cancer patients, the effects of undergoing a mastectomy go well beyond the physical.

Read more »

Cytori Therapeutics at the 2010 OneMedForum

Chris Calhoun, CEO of Cytori Therapeutics, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in […]

Read more »

Healthcare Conference Updates: AUXL, CTIC, CYTX, KERX

Below are some updates and developments from the past week.

Read more »

Cytori’s (NASDAQ: CYTX) Natural Celution for Breast Reconstruction

Cytori Therapeutics is a leading global innovator in the emerging field of regenerative medicine using adipose (fat) tissue as a rich source of adult stem cells capable of differentiating into a variety of cell types.

Read more »

Cellular Reprogramming May Offer Stem-Cell Compromise

President Obama’s recent reversal of Bush’s policy on embryonic stem cell research reignited the debate over the ethical limits of science. However, as the Wall Street Journal reports, an innovative new technique could potentially reproduce the benefits of embryonic stem cells without the attendant controversy.

Read more »